Company / Gross Margin
ENvue Medical, Inc. Gross Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
59.0%
FY2025
5-year range
22.2% / 67.3%
FY2021-FY2025
Trend
-12.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Margin has fluctuated over the past 10 years, ranging from 22.2% in FY2023 to 67.3% in FY2024.
Based on SEC 10-K filings.
59.0% in FY2025 with a 5-year CAGR of +5.9%.
Improved from 22.2% to 59.0% over the past 2 years.
Gross Margin over time
Growth rates
- 3-Year Change
- +13.5pp
- 5-Year Change
- +5.9pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, gross margin decreased 12.4% year-over-year.
- Peak gross margin was recorded in FY2024.
- Lowest gross margin in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.19 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 59.0% | -12.4% |
| FY2024 | 67.3% | +203.1% |
| FY2023 | 22.2% | -51.1% |
| FY2022 | 45.4% | +32.3% |
| FY2021 | 34.4% | -35.2% |
| FY2020 | 53.0% | +5.4% |
| FY2019 | 50.3% | -20.4% |
| FY2018 | 63.2% | +2.6% |
| FY2017 | 61.6% | -7.6% |
| FY2016 | 66.7% | +23.0% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026